

Cover Story
By Paul Goldberg and Matthew Bin Han Ong
Is Average Sales Price plus 6 percent the right amount to pay doctors under the Medicare Part B program?
In Brief


Drugs & Targets


Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned










